Cervical cancer is the second most frequent cancer among women in Kenya and the leading cause of mortality in the same group. Nearly all cervical cancers are caused by infection with different types of human papillomavirus (HPV), with the most prevalent being HPV16 and HPV 18. Latest data from 2023 show that Kenya has an annual incidence of 5236 cervical cancer cases, with a mortality of 3211 patients. To lower the burden of cervical cancer, the Government of Kenya introduced HPV vaccination in late 2019 using a blend between community, facility, and school-based strategies. The vaccination targeted school-going girls aged 10-14 who are not yet sexually active and, therefore, unlikely to have HPV infection.